| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Lourdes Alvarez-Arellano | Q89878303 |
| P2093 | author name string | C Maldonado-Bernal | |
| D M Abarca-Merlin | |||
| P2860 | cites work | Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function | Q24317859 |
| Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration | Q24614960 | ||
| Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis | Q24645038 | ||
| The Yin and Yang of Toll-like receptors in cancer | Q26851526 | ||
| HMGB1 mediates endogenous TLR2 activation and brain tumor regression | Q27307459 | ||
| The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors | Q27860900 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Type I interferon is selectively required by dendritic cells for immune rejection of tumors | Q28248500 | ||
| The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults | Q28289939 | ||
| Toll-like receptors in innate immunity | Q28297257 | ||
| Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation | Q28508164 | ||
| Cancer immunotherapy via dendritic cells | Q29615444 | ||
| Toll-like receptor signaling in cell proliferation and survival | Q33598805 | ||
| Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer | Q33707487 | ||
| Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study | Q34132839 | ||
| Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential | Q34510368 | ||
| Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity | Q34586673 | ||
| Recent advances in the role of toll-like receptors and TLR agonists in immunotherapy for human glioma | Q34657329 | ||
| Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy | Q34764143 | ||
| Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors | Q40244018 | ||
| Borrelia burgdorferi induces inflammatory mediator production by murine microglia | Q40704718 | ||
| The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses | Q41779891 | ||
| Toll-like receptor 2 mediates proliferation, survival, NF-kappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells | Q41894791 | ||
| Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation | Q41979125 | ||
| A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans | Q42657549 | ||
| Toll-like receptor 3 signaling induces apoptosis in human head and neck cancer via survivin associated pathway. | Q43049482 | ||
| TLR ligands in the local treatment of established intracerebral murine gliomas. | Q44062204 | ||
| Broad expression of Toll-like receptors in the human central nervous system | Q44492400 | ||
| Inhibitory effect of dsRNA TLR3 agonist in a rat hepatocellular carcinoma model | Q47719072 | ||
| Cultured astrocytes express toll-like receptors for bacterial products | Q48235492 | ||
| TLR2 controls random motility, while TLR7 regulates chemotaxis of microglial cells via distinct pathways. | Q48555879 | ||
| Systemic injection of TLR1/2 agonist improves adoptive antigen-specific T cell therapy in glioma-bearing mice | Q48716447 | ||
| Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. | Q54400192 | ||
| Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs. | Q54978764 | ||
| Plasmatic membrane toll-like receptor expressions in human astrocytomas. | Q55279509 | ||
| Toll-like receptors as an innate immunity bridge to neuroinflammation in medulloblastoma. | Q55461803 | ||
| Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs. | Q55475484 | ||
| Toll-like Receptor-4 is a Mediator of Proliferation in Esophageal Adenocarcinoma | Q57185906 | ||
| A Novel Toll-Like Receptor 9 Agonist Cooperates with Trastuzumab in Trastuzumab-Resistant Breast Tumors through Multiple Mechanisms of Action | Q57424219 | ||
| c-Jun N-terminal kinases differentially regulate TNF- and TLRs-mediated necroptosis through their kinase-dependent and -independent activities | Q59136662 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| TLR-4/Wnt modulation as new therapeutic strategy in the treatment of glioblastomas | Q61455087 | ||
| Targeting Tumor Microenvironment for Cancer Therapy | Q64259998 | ||
| Characterization of microglial responses to Staphylococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression | Q74775345 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| Differential activation of astrocytes by innate and adaptive immune stimuli | Q80990228 | ||
| The activation of Toll-like receptor 4 reverses tumor differentiation in human glioma U251 cells via Notch pathway | Q91142078 | ||
| TLR8 and its endogenous ligand miR-21 contribute to neuropathic pain in murine DRG | Q93221565 | ||
| Topical imiquimod has therapeutic and immunomodulatory effects against intracranial tumors | Q34777706 | ||
| TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo. | Q35531400 | ||
| Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors | Q35751039 | ||
| Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma | Q35800532 | ||
| Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trial | Q36092885 | ||
| Mammalian Toll-like receptors: to immunity and beyond | Q36149113 | ||
| Toll-like receptors in central nervous system glial inflammation and homeostasis | Q36422953 | ||
| TLR4-activated microglia require IFN-γ to induce severe neuronal dysfunction and death in situ | Q36459512 | ||
| SARM1, Not MyD88, Mediates TLR7/TLR9-Induced Apoptosis in Neurons | Q36625878 | ||
| TLR9 mediates cellular protection by modulating energy metabolism in cardiomyocytes and neurons | Q36729539 | ||
| Development of TLR9 agonists for cancer therapy | Q36809776 | ||
| Toll-like receptors in the brain and their potential roles in neuropathology. | Q36898647 | ||
| The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes | Q36949738 | ||
| Application potential of toll-like receptors in cancer immunotherapy: Systematic review | Q37205171 | ||
| Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion | Q37268889 | ||
| Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity | Q37286656 | ||
| Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression | Q37665498 | ||
| RAGE regulation and signaling in inflammation and beyond. | Q38094691 | ||
| Toll-like receptors: Activation, signalling and transcriptional modulation. | Q38407658 | ||
| Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression | Q38721207 | ||
| Pivotal role of high-mobility group box 1 (HMGB1) signaling pathways in glioma development and progression | Q38855171 | ||
| Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword | Q38878794 | ||
| Distinctive responses of brain tumor cells to TLR2 ligands | Q38915803 | ||
| Structures and recognition modes of toll-like receptors | Q38971732 | ||
| Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter? | Q39223354 | ||
| Regulatory effects of Spirulina complex polysaccharides on growth of murine RSV-M glioma cells through Toll-like receptor 4. | Q39248369 | ||
| Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses | Q39398295 | ||
| Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells | Q39411130 | ||
| Involvement of TNFα-induced TLR4-NF-κB and TLR4-HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma. | Q39480423 | ||
| Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells | Q39501063 | ||
| Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis. | Q39925824 | ||
| Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis | Q39932687 | ||
| In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma | Q40042353 | ||
| The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4. | Q40172870 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| immunotherapy | Q1427096 | ||
| central nervous system neoplasm | Q4335557 | ||
| P304 | page(s) | 5286358 | |
| P577 | publication date | 2019-05-21 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | Toll-Like Receptors as Therapeutic Targets in Central Nervous System Tumors | |
| P478 | volume | 2019 |
| Q99711410 | Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme | cites work | P2860 |
Search more.